Online Seminar: The Health of Biopharma - Trends in Investments and ExitsMay 09, 2011 Posted by: Ashraf Hebela, CFA
Join our panel of experts on biopharma valuations and venture capital investment in , where they discuss the results of SVB Analytics' latest research findings. Our panel presents and discusses a range of data on operating performance, venture funding and valuations, and exit activity.
[PLAYBACK] (PDF) (PDF)
Among the topics we will discuss:
A Venture Capital perspective on early and late stage investments in the biopharma sector Recent data on exit multiples, and time-and capital-to-exit SVB Analytics' perspective on biopharma valuations Trends in operating performance Speakers:
, Managing Director, Silicon Valley Bank (moderator) , MD, PhD, General Partner, Sofinnova Ventures , Head of Prod Management, SVB Analytics , Research Associate, SVB Analytics Read More